Episode 54
Biotech Hangout
00:00
The Future of R&D Decision Making Process With the IRA Rules
There was a really good pharma R&D summit hosted by a bunch of folks and John Reed and David Reese and Michael Doulson were there. The key panel that I was on related to whether R&D decision making process was going to be changed with the forthcoming IRA rules. For small molecules, you know, inherently actually drives innovation away from cardiovascular pills,. or pills for cancer and over favors, biologics for orphan diseases.
Transcript
Play full episode
